Get access to our best features
Get access to our best features
Published 19 days ago

No link between Ozempic, Wegovy and suicide, EU drug regulators say

  • European Union drug regulators have found no evidence that popular weight loss and diabetes drugs are linked to an increased risk of suicidal thoughts, as stated in the investigation by the European Medicines Agency.
  • The investigation focused on GLP-1s, a class of drugs that suppress appetite by mimicking a gut hormone. Despite high demand and cost, these drugs have limited insurance coverage.
  • The drugs Wegovy and Ozempic, among others, were the center of the investigation, which concluded with no evidence of a link to self-injury, as reported by the regulator.
Insights by Ground AI
Does this summary seem wrong?

0 Articles

All
Left
Center
Right
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 66% of the sources are Center
66% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)